2 news items
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response
ARVN
ATOS
ICCM
30 Apr 24
briefing document. The company looks forward to meeting with the FDA in Q2 2024 to finalize the trial design and goals for using pelareorep in treating
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response
ARVN
ATOS
ICCM
30 Apr 24
and persuasive briefing document. The company looks forward to meeting with the FDA in Q2 2024 to finalize the trial design and goals for using pelareorep
- Prev
- 1
- Next